Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016
"Prostaglandin
E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) -
Pipeline Review, H2 2016"
The Report covers current Market Trends, Worldwide Analysis, Global
Forecast, Review, Share, Size, Growth, Effect.
Description-
Prostaglandin
E2 Receptor EP2
Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2
2016, provides in depth analysis on Prostaglandin E2 Receptor EP2
Subtype (Prostanoid EP2 Receptor or PTGER2) targeted pipeline
therapeutics.
The
report provides comprehensive information on the Prostaglandin E2
Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2), targeted
therapeutics, complete with analysis by indications, stage of
development, mechanism of action (MoA), route of administration (RoA)
and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases. Additionally,
the report provides an overview of key players involved in
Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or
PTGER2) targeted therapeutics development and features dormant and
discontinued projects.
Scope
-
The report provides a snapshot of the global therapeutic landscape
for Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or
PTGER2)
-
The report reviews Prostaglandin E2 Receptor EP2 Subtype (Prostanoid
EP2 Receptor or PTGER2) targeted therapeutics under development by
companies and universities/research institutes based on information
derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
Reasons
to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand the targeted therapy areas and indications
for Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or
PTGER2)
-
Identify the use of drugs for target identification and drug
repurposing
-
Identify potential new clients or partners in the target demographic
For
More Information Kindly Contact:
ResearchMoz
Global Pvt. Ltd.
90
State Street,
Albany, NY 12207,
United Stateshttp://www.researchmoz.us,Blog - http://bit.ly/2b1Ayn6 866-997-4948 (Us-Canada Toll Free),
+1-518-621-2074,Email to: sales@researchmoz.us,
Albany, NY 12207,
United Stateshttp://www.researchmoz.us,Blog - http://bit.ly/2b1Ayn6 866-997-4948 (Us-Canada Toll Free),
+1-518-621-2074,Email to: sales@researchmoz.us,
Comments
Post a Comment